Cancer Research UK scientists have created the first 3D structure of a key protein that protects against the development of cancer, according to research published in Nature Structural & Molecular Biology.
23 January 2012
Horizon Discovery (Horizon), a leading provider of research tools to support the development of personalized medicines, has announced that it has entered into a 3-year collaboration with the Fox Chase Cancer Center (Fox Chase). The focus of the collaboration is to apply rAAV gene targeting in mouse embryonic stem (ES) cells, and for the discovery of genes involved in resistance to EGFR-targeted therapies in human cancer, such as PI3K.
19 April 2011
Cyprotex is giving researchers free online access to its database of the ADME and pharmacokinetic properties of marketed drugs via its online Cloe® Knowledge data visualization and interpretation tool.
01 September 2010
Numerate and Intellikine have announced the successful conclusion of their research collaboration to discover novel small-molecule compounds targeting the PI3K/mTOR signaling pathway.
11 August 2010
Royal Philips Electronics and Dako, a Danish company specializing in tissue-based cancer diagnostics, have signed an agreement to integrate a selection of Dako's image analysis applications into Philips' future digital pathology solutions.
22 July 2010
Roche and IBM are collaborating to develop a nanopore-based sequencer that will read and decode human DNA quickly and efficiently, with the aim of accelerating human genome analysis and advancing personalized healthcare.
01 July 2010
Name a human gene, and you can find a movie online showing you what happens to cells when it is switched off.
31 March 2010
ChEMBLdb, an online database of information on the properties of drugs and drug-like small molecules and their targets, has launched with information on more than half a million compounds.
28 January 2010
'The Robot Scientist' first to complete experimentation cycle without human involvement.
25 January 2010
Domainex Ltd. has released the next generation of its LeadBuilder virtual screening technology. LeadBuilder is the proprietary lead generation platform developed by Domainex to provide unusually rapid and cost-effective access to high-quality small-molecule drug leads, particularly against novel or difficult target proteins.
03 December 2009